|
Information was received from healthcare provider (hcp) via a manufacturer representative regarding a patient having spinal therapy for pre-op diagnosis of osteoporosis with compression fracture.It was reported that inflatable bone tamp was ruptured during infla tion. contrast leakage was observed, so the use of the contrast medium was stopped, and after saline rinsing was performed.The contrast medium was replaced with an alternative and the procedure was continued.The pressure in ibt was 240psi before it ruptured. the procedure or technique performed was th10 balloon kyphoplasty.No time delay in procedure reported as a result.There was no fragment of ruptured balloon was left inside patient body.There were no patient symptoms reported.No additional treatment or surgery performed as a result.No further complications reported regarding the event.
|
|
H6: neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|